4.7 Review

Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways

Related references

Note: Only part of the references are listed.
Review Critical Care Medicine

Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis

Satoshi Gando et al.

Summary: This article discusses the pathomechanisms and treatment strategies for hypoxemia in ARDS induced by COVID-19. The study found that COVID-19-associated ARDS is more vascular centric and different types of ARDS have different mechanisms of hypoxemia. The main reasons for hypoxemia in type H and L ARDS are right-to-left shunts and high VA/Q ratios, respectively. Early anticoagulation therapy may improve the prognosis of COVID-19 patients.

SHOCK (2022)

Review Virology

Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis

Mohitosh Biswas et al.

Summary: The study found that male patients, patients over 50, and patients with comorbidities such as kidney disease and cerebrovascular disease were significantly more at risk of mortality from COVID-19. However, liver disease did not show a significant association with mortality risk.

INTERVIROLOGY (2021)

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Review Cardiac & Cardiovascular Systems

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation

Sean X. Gu et al.

Summary: Platelet and endothelial dysfunction are essential components of COVID-19 pathology, while cardiovascular risk factors exacerbate the severity of the disease. Patients with pre-existing cardiovascular disease and risk factors are at the highest risk of death from COVID-19.

NATURE REVIEWS CARDIOLOGY (2021)

Editorial Material Pharmacology & Pharmacy

A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications

Cameron G. McCarthy et al.

VASCULAR PHARMACOLOGY (2021)

Article Medicine, General & Internal

First Cases of Multisystem Inflammatory Syndrome following SARS-CoV-2 infection in Adults in Germany

Karl Rieper et al.

Summary: Multisystem Inflammatory Syndrome is a rare condition that can affect multiple organs, presenting with a variety of symptoms. With the ongoing SARS-CoV-2 pandemic, an increasing number of cases in adults can be expected. Early consideration of Multisystem Inflammatory Syndrome in therapy, including corticosteroids, aspirin, and immunoglobulins, may be more effective in managing the condition.

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2021)

Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

Article Microbiology

The Balance of Neutrophil Extracellular Trap Formation and Nuclease Degradation: an Unknown Role of Bacterial Coinfections in COVID-19 Patients?

Nicole de Buhr et al.

Summary: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing public health crises globally, and neutrophil extracellular traps (NETs) have been identified as a potential driver of severe infections. However, the degradation of NETs by DNase treatment may also enhance certain bacterial coinfections, exacerbating the severity of the disease.
Article Pathology

Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein *

Gerard J. Nuovo et al.

Summary: Neurologic complications of symptomatic COVID-19 are commonly seen, with brain tissues from autopsies showing the presence of pseudovirions in endothelial cells. The spike protein was found to induce ACE2+ endothelial damage, highlighting its central role in SARS-CoV2 pathology. Immunohistochemistry for caspase-3 and ACE2 can be used by diagnostic pathologists to document endothelial cell damage in COVID-19.

ANNALS OF DIAGNOSTIC PATHOLOGY (2021)

Letter Cardiac & Cardiovascular Systems

SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2

Yuyang Lei et al.

CIRCULATION RESEARCH (2021)

Article Cell Biology

Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone

Olumayokun A. Olajide et al.

Summary: The study found that SARS-CoV-2 spike glycoprotein S1 stimulated PBMCs to release pro-inflammatory cytokines through mechanisms involving activation of NF-kappa B, p38 MAPK, and NLRP3 inflammasome. The clinical benefits of dexamethasone in COVID-19 may be due to its anti-inflammatory activity in reducing SARS-CoV-2 cytokine storm.

INFLAMMATION (2021)

Article Medicine, General & Internal

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

Isaac See et al.

Summary: Cases of CVST with thrombocytopenia following Ad26.COV2.S vaccination have been reported in the US, leading to serious outcomes. This case series may provide guidance for clinical management and further investigation into the potential relationship between Ad26.COV2.S vaccine and CVST with thrombocytopenia.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Immunology

Contribution of STAT3 to the pathogenesis of COVID-19

Abdollah Jafarzadeh et al.

Summary: COVID-19 pathogenesis involves hyper-inflammatory responses, unbalanced immune responses, cytokine storm, and the involvement of STAT-3 which can lead to lung fibrosis and thrombosis.

MICROBIAL PATHOGENESIS (2021)

Article Medicine, General & Internal

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

Marie Scully et al.

Summary: 23 cases of thrombotic thrombocytopenia were reported after receiving the AstraZeneca vaccine, incited by antibodies to platelet factor 4 and unrelated to heparin therapy. Avoidance of platelet transfusion and consideration of nonheparin anticoagulant and intravenous immune globulin are recommended for treatment.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Medicine, General & Internal

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

Kate-Lynn Muir et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Nina H. Schultz et al.

Summary: This study reports five cases of venous thrombosis and thrombocytopenia occurring 7 to 10 days after receiving the ChAdOx1 nCoV-19 vaccine, suggesting a rare vaccine-induced immune thrombotic thrombocytopenia. The condition, which can lead to catastrophic outcomes such as cerebral venous sinus thrombosis, may be treated with intravenous immune globulin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Medicine, General & Internal

Thrombosis after covid-19 vaccination These rare events must not derail vaccination efforts

Paul R. Hunter

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Genetics & Heredity

SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription

Abdulaziz Almuqrin et al.

Summary: The ChAdOx1 nCoV-19 vaccine demonstrated expected transcriptomic and proteomic profiles in cell culture, with the SARS-CoV-2 S coding transcript dominating in all cell lines and rare adenovirus gene expression in A549 cells comparatively. This study highlights the potential for future viral vaccine vector design based on detailed insights gained from advanced transcriptomic and proteomic analyses.

GENOME MEDICINE (2021)

Article Physiology

The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in K18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells

Ruben M. L. Colunga Biancatelli et al.

Summary: Research suggests that intratracheal instillation of the S1 subunit of the SARS-CoV-2 spike protein in K18-hACE2 transgenic mice can induce COVID-19-associated lung injury, characterized by weight loss, increased white blood cells and protein concentration, upregulated inflammatory cytokines, histological evidence of lung injury, and activation of specific pathways.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)

Review Medicine, Research & Experimental

Roles of Coagulation Abnormalities and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment

Toshiaki Iba et al.

Summary: The diagnostic criteria for overt DIC were established by ISTH in 2001, with recent research shedding light on the role of coagulation disorders in sepsis progression. The introduction of SIC as a pragmatic scoring system aims to detect early-stage sepsis-associated DIC, while globally agreed anticoagulant therapy for DIC is still lacking. International collaborative studies are deemed necessary for future advancements in diagnostic tools and treatment strategies.

ARCHIVES OF MEDICAL RESEARCH (2021)

Review Biochemistry & Molecular Biology

Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?

Rossella Talotta et al.

Summary: Antiphospholipid antibodies (aPLs), present in 1-5% of healthy individuals, may play a role in the pathogenesis of rare adverse events following COVID-19 vaccination. These antibodies can activate coagulation factors and induce abnormal platelet activation, potentially leading to thrombotic events. Further investigations are warranted to determine the exact association between aPLs and thrombotic events post-vaccination.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

News Item Multidisciplinary Sciences

COVID VACCINES AND BLOOD CLOTS: WHAT RESEARCHERS KNOW SO FAR

Heidi Ledford

NATURE (2021)

Review Immunology

COVID-19: Lung-Centric Immunothrombosis

Peter R. Kvietys et al.

Summary: Respiratory tract infection caused by SARS-CoV-2 can lead to acute respiratory distress syndrome (ARDS) and death. Overactive innate immune response is a major factor in ARDS development in COVID-19 patients. The formation of neutrophil extracellular traps (NETs) can trigger immunothrombosis, resulting in blood vessel occlusion and ischemic damage.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Review Immunology

The Many Faces of JAKs and STATs Within the COVID-19 Storm

Alice H. Grant et al.

Summary: The SARS-CoV-2 virus has caused a global pandemic with devastating health and economic consequences. Immunologically, the effects of SARS-CoV-2 are traced back to a cytokine storm that activates the JAK-STAT pathway. Therapeutic strategies to combat the SARS-CoV-2 mediated storm focus on cell signaling and JAK inhibition.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

The signal pathways and treatment of cytokine storm in COVID-19

Lan Yang et al.

Summary: The COVID-19 pandemic is a global crisis with devastating effects, where immunopathology plays a crucial role in disease progression, particularly the cytokine storm which has a significant impact on prognosis. Understanding and targeting the pathways involved in cytokine storm could lead to more effective treatment strategies for COVID-19.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Immunology

The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients

Apurva Hariharan et al.

Summary: COVID-19 causes a cytokine storm mainly affecting the lungs, with elderly and patients with metabolic syndrome being more susceptible. Immunomodulation targeting NF-kappa B activation and inhibitors can potentially reduce the cytokine storm, alleviating the severity of COVID-19. Inhibition of the NF-kappa B pathway may play a therapeutic role in alleviating severe forms of COVID-19.

INFLAMMOPHARMACOLOGY (2021)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Critical Care Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu et al.

LANCET RESPIRATORY MEDICINE (2020)

Editorial Material Immunology

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome

Toshio Hirano et al.

IMMUNITY (2020)

Editorial Material Multidisciplinary Sciences

Cytokine release syndrome in severe COVID-19

John B. Moore et al.

SCIENCE (2020)

Article Hematology

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Jecko Thachil et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, General & Internal

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

Thomas J. Oxley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, Research & Experimental

Rationale for targeting complement in COVID-19

Anastasia Polycarpou et al.

EMBO MOLECULAR MEDICINE (2020)

Article Medicine, General & Internal

Vascular occlusion by neutrophil extracellular traps in COVID-19

Moritz Leppkes et al.

EBIOMEDICINE (2020)

Review Immunology

COVID-19: Complement, Coagulation, and Collateral Damage

Martin W. Lo et al.

JOURNAL OF IMMUNOLOGY (2020)

Article Biochemical Research Methods

Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level

Angelo D'Alessandro et al.

JOURNAL OF PROTEOME RESEARCH (2020)

Review Biochemistry & Molecular Biology

An aberrant STAT pathway is central to COVID-19

Toshifumi Matsuyama et al.

CELL DEATH AND DIFFERENTIATION (2020)

Article Biotechnology & Applied Microbiology

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

Robert Lorenz Chua et al.

NATURE BIOTECHNOLOGY (2020)

Article Immunology

Are superantigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis

Valeria Scaglioni et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jerome Hadjadj et al.

SCIENCE (2020)

Article Medicine, Research & Experimental

Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

Panagiotis Skendros et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Oncology

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

Si Zhang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

Girish N. Nadkarni et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Multidisciplinary Sciences

Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation

Mary Hongying Cheng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

Jan C. Holter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Hematology

Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review

Alexander Fletcher-Sandersjoo et al.

THROMBOSIS RESEARCH (2020)

Review Immunology

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses

Zeinab Abdelrahman et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Extracellular DNA-A Danger Signal Triggering Immunothrombosis

Chongxu Shi et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Cell Biology

SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity

Ganna Petruk et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2020)

Editorial Material Medicine, General & Internal

Asymptomatic transmission of covid-19

Allyson M. Pollock et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Immunology

NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients

Ralf Kircheis et al.

FRONTIERS IN IMMUNOLOGY (2020)

Letter Biochemistry & Molecular Biology

GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro

Kyung Soo Hong et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Cell Biology

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Yu Zuo et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Multidisciplinary Sciences

Age-specific mortality and immunity patterns of SARS-CoV-2

Megan O'Driscoll et al.

NATURE (2020)

Review Infectious Diseases

Age-Related Morbidity and Mortality among Patients with COVID-19

Seung-Ji Kang et al.

INFECTION AND CHEMOTHERAPY (2020)

Review Immunology

The trinity of COVID-19: immunity, inflammation and intervention

Matthew Zirui Tay et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Integrative & Complementary Medicine

Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-kappa B and MAPKs signalings

Jiashun Li et al.

BMC COMPLEMENTARY MEDICINE AND THERAPIES (2020)

Review Immunology

How COVID-19 induces cytokine storm with high mortality

Shintaro Hojyo et al.

INFLAMMATION AND REGENERATION (2020)

Review Biochemistry & Molecular Biology

Role of NF-κB in Platelet Function

Kevin Kojok et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Immunology

Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis

Marion Mussbacher et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration

James M. Fox et al.

SCIENTIFIC REPORTS (2018)

Article Urology & Nephrology

Thrombotic Microangiopathy and the Kidney

Vicky Brocklebank et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)

Review Medicine, General & Internal

Thrombotic microangiopathies: a general approach to diagnosis and management

Donald M. Arnold et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2017)

Article Chemistry, Analytical

Manipulating adenoviral vector ion-exchange chromatography: Hexon versus fiber

Jelena Ruscic et al.

JOURNAL OF SEPARATION SCIENCE (2016)

Article Multidisciplinary Sciences

NF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector

M. Machitani et al.

SCIENTIFIC REPORTS (2016)

Review Medicine, General & Internal

Syndromes of Thrombotic Microangiopathy

James N. George et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Immunology

A new look at T cell receptor signaling to nuclear factor-κB

Suman Paul et al.

TRENDS IN IMMUNOLOGY (2013)

Review Hematology

Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis

M. Anna Kowalska et al.

THROMBOSIS RESEARCH (2010)

Article Hematology

Effect of vectors on human endothelial cell signal transduction - Implications for cardiovascular gene therapy

PH Tan et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Nuclear factor kappa B mediates a procoagulant response in monocytes during extracorporeal circulation

EN Morgan et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)

Article Biochemistry & Molecular Biology

α5β1 integrin activates an NF-κB-dependent program of gene expression important for angiogenesis and inflammation

S Klein et al.

MOLECULAR AND CELLULAR BIOLOGY (2002)